Compare TLX & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLX | KTB |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | N/A | N/A |
| Metric | TLX | KTB |
|---|---|---|
| Price | $9.02 | $66.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $21.00 | ★ $96.38 |
| AVG Volume (30 Days) | 115.0K | ★ 643.7K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.04 | ★ 3.88 |
| Revenue | $664,225,558.00 | ★ $2,833,659,000.00 |
| Revenue This Year | N/A | $20.46 |
| Revenue Next Year | N/A | $11.11 |
| P/E Ratio | $284.97 | ★ $17.15 |
| Revenue Growth | ★ 55.35 | 9.91 |
| 52 Week Low | $8.76 | $50.00 |
| 52 Week High | $30.36 | $96.80 |
| Indicator | TLX | KTB |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 35.32 |
| Support Level | $9.37 | $65.89 |
| Resistance Level | $10.03 | $69.73 |
| Average True Range (ATR) | 0.25 | 2.75 |
| MACD | -0.00 | -0.54 |
| Stochastic Oscillator | 7.65 | 5.41 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.